FAP and neoplasm: Gallium-68-labeled fibroblast activation protein (FAP) inhibitor ([68Ga]Ga-FAPI-04) have attracted attention as promising radiotracers since 2019 owing to their superior ability to bind to FAP in the tumor stroma (21).